Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn’s disease

被引:0
作者
Akira Andoh
Hiroyuki Kuzuoka
Tomoyuki Tsujikawa
Shiro Nakamura
Fumihito Hirai
Yasuo Suzuki
Toshiyuki Matsui
Yoshihide Fujiyama
Takayuki Matsumoto
机构
[1] Graduate School,Division of Mucosal Immunology
[2] Shiga University of Medical Science,Department of Lower Gastroenterology
[3] Hyogo College of Medicine,Research and Development Laboratories
[4] EN Otsuka Pharmaceutical Co.,Department of Gastroenterology
[5] Ltd.,Department of Internal Medicine
[6] Fukuoka University Chikushi Hospital,Department of Medicine
[7] Toho University Sakura Medical Center,undefined
[8] Shiga University of Medical Science,undefined
来源
Journal of Gastroenterology | 2012年 / 47卷
关键词
Inflammatory bowel disease; Shannon diversity index; T-RFLP;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1298 / 1307
页数:9
相关论文
共 50 条
  • [21] Role of gut microbiota in Crohn's disease pathogenesis: Insights from fecal microbiota transplantation in mouse model
    Wu, Qiang
    Yuan, Lian-Wen
    Yang, Li-Chao
    Zhang, Ya-Wei
    Yao, Heng-Chang
    Peng, Liang-Xin
    Yao, Bao-Jia
    Jiang, Zhi-Xian
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (31) : 3689 - 3704
  • [22] Fecal microbiota and metabolites are distinct in a pilot study of pediatric Crohn's disease patients with higher levels of perceived stress
    Mackner, Laura M.
    Hatzakis, Emmanuel
    Allen, Jacob M.
    Davies, Ronald H.
    Kim, Sandra C.
    Maltz, Ross M.
    Bailey, Michael T.
    PSYCHONEUROENDOCRINOLOGY, 2020, 111
  • [23] The gastric microbiota in patients with Crohn's disease; a preliminary study
    Ostrowski, Jerzy
    Kulecka, Maria
    Zawada, Iwona
    Zeber-Lubecka, Natalia
    Paziewska, Agnieszka
    Graca-Pakulska, Katarzyna
    Dabkowski, Krzysztof
    Skubisz, Karolina
    Cybula, Patrycja
    Ambrozkiewicz, Filip
    Urasinska, Elzbieta
    Mikula, Michal
    Starzynska, Teresa
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [24] Characterization of gut microbiota profiles by disease activity in patients with Crohn's disease using data mining analysis of terminal restriction fragment length polymorphisms
    Andoh, Akira
    Kobayashi, Toshio
    Kuzuoka, Hiroyuki
    Tsujikawa, Tomoyuki
    Suzuki, Yasuo
    Hirai, Fumihito
    Matsui, Toshiyuki
    Nakamura, Shiro
    Matsumoto, Takayuki
    Fujiyama, Yoshihide
    BIOMEDICAL REPORTS, 2014, 2 (03) : 370 - 373
  • [25] Monitoring-Based Model for Personalizing Fecal Incontinence in Patients With Crohn's Disease: A Multicenter Inception Cohort Study
    Wang, Can
    Yang, Fan
    Qiao, Lichao
    Wang, Xiaoxiao
    Chen, Qi
    Chen, Hongjin
    Li, Yi
    Zhang, Xiaoqi
    Liao, Xiujun
    Cao, Lei
    Xu, Haixia
    Xiang, Yu
    Yang, Bolin
    INFLAMMATORY BOWEL DISEASES, 2024, 30 (12) : 2314 - 2322
  • [26] Increased Intestinal Microbial Diversity Following Fecal Microbiota Transplant for Active Crohn's Disease
    Vaughn, Byron P.
    Vatanen, Tommi
    Allegretti, Jessica R.
    Bai, Aiping
    Xavier, Ramnik J.
    Korzenik, Joshua
    Gevers, Dirk
    Ting, Amanda
    Robson, Simon C.
    Moss, Alan C.
    INFLAMMATORY BOWEL DISEASES, 2016, 22 (09) : 2182 - 2190
  • [27] Fecal fungal microbiota alterations associated with clinical phenotypes in Crohn's disease in southwest China
    Zeng, Li
    Feng, Zhe
    Zhuo, Ma
    Wen, Zhonghui
    Zhu, Cairong
    Tang, Chengwei
    Liu, Ling
    Wang, Yufang
    PEERJ, 2022, 10
  • [28] Fecal microbiota transplantation to maintain remission in Crohn's disease: a pilot randomized controlled study
    Sokol, Harry
    Landman, Cecilia
    Seksik, Philippe
    Berard, Laurence
    Montil, Melissa
    Nion-Larmurier, Isabelle
    Bourrier, Anne
    Le Gall, Guillaume
    Lalande, Valerie
    De Rougemont, Alexis
    Kirchgesner, Julien
    Daguenel, Anne
    Cachanado, Marine
    Rousseau, Alexandra
    Drouet, Elodie
    Rosenzwajg, Michelle
    Hagege, Nerve
    Dray, Xavier
    Klatzman, David
    Marteau, Philippe
    Beaugerie, Laurent
    Simon, Tabassome
    MICROBIOME, 2020, 8 (01)
  • [29] Fecal Microbiota Alterations Associated With Clinical and Endoscopic Response to Infliximab Therapy in Crohn's Disease
    Zhuang, Xiaojun
    Tian, Zhenyi
    Feng, Rui
    Li, Manying
    Li, Tong
    Zhou, Gaoshi
    Qiu, Yun
    Chen, Baili
    He, Yao
    Chen, Minhu
    Zeng, Zhirong
    Zhang, Shenghong
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (11) : 1636 - 1647
  • [30] Validation of Risk Factors for Fecal Incontinence in Patients With Crohn's Disease
    Vollebregt, Paul F.
    Visscher, Arjan P.
    van Bodegraven, Adriaan A.
    Felt-Bersma, Richelle J. F.
    DISEASES OF THE COLON & RECTUM, 2017, 60 (08) : 845 - 851